• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将MSA1信号序列和锚定序列添加到疟原虫裂殖子表面抗原1的C末端区域,通过重组痘苗病毒表达时可增强免疫原性。

Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.

作者信息

Yang S, Carroll M W, Torres-Duarte A P, Moss B, Davidson E A

机构信息

Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, NW Washington, DC 20007, USA.

出版信息

Vaccine. 1997 Aug-Sep;15(12-13):1303-13. doi: 10.1016/s0264-410x(97)00039-x.

DOI:10.1016/s0264-410x(97)00039-x
PMID:9302735
Abstract

Genes encoding four different C-terminal fragments of a Plasmodium falciparum merozoite surface antigen were generated: MSA1C-(Si,A), containing signal and anchor regions of MSA1; MSA1C-(Si,nA), containing the signal but not the anchor; MSA1C-(nSi,A), containing the anchor but not the signal, and MSA1C-(nSi,nA) containing neither the signal nor the anchor region. Each gene was inserted into the thymidine kinase region of vaccinia virus, under the control of a synthetic strong early/ late promoter. When the plasmodial genes were expressed in cells infected by the recombinant vaccinia virus, the two proteins containing the signal region were transported to the surface of infected cells. Infection of mice and rabbits with the latter recombinant viruses stimulated C-terminal-specific antibody levels that were 10-80-fold higher than those induced by the two recombinant viruses without the signal region. The combination of the signal and anchor regions with the C-terminal MSA1 protein also generated the most effective neutralization in a P. falciparum invasion assay.

摘要

构建了编码恶性疟原虫裂殖子表面抗原四种不同C末端片段的基因:MSA1C-(Si,A),包含MSA1的信号和锚定区域;MSA1C-(Si,nA),包含信号但不包含锚定区域;MSA1C-(nSi,A),包含锚定区域但不包含信号;以及MSA1C-(nSi,nA),既不包含信号区域也不包含锚定区域。每个基因都在合成的强早期/晚期启动子的控制下插入痘苗病毒的胸苷激酶区域。当疟原虫基因在重组痘苗病毒感染的细胞中表达时,两种包含信号区域的蛋白质被转运到感染细胞的表面。用后两种重组病毒感染小鼠和兔子,刺激产生的C末端特异性抗体水平比由没有信号区域的两种重组病毒诱导产生的抗体水平高10 - 80倍。在恶性疟原虫入侵试验中,信号和锚定区域与C末端MSA1蛋白的组合也产生了最有效的中和作用。

相似文献

1
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus.将MSA1信号序列和锚定序列添加到疟原虫裂殖子表面抗原1的C末端区域,通过重组痘苗病毒表达时可增强免疫原性。
Vaccine. 1997 Aug-Sep;15(12-13):1303-13. doi: 10.1016/s0264-410x(97)00039-x.
2
Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.约氏疟原虫裂殖子表面蛋白1不同区域重组蛋白免疫诱导的保护作用比较
Infect Immun. 1997 Aug;65(8):3032-6. doi: 10.1128/iai.65.8.3032-3036.1997.
3
Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus.由痘苗病毒表达的恶性疟原虫富含谷氨酸蛋白的免疫原性。
Infect Immun. 1994 Aug;62(8):3270-5. doi: 10.1128/iai.62.8.3270-3275.1994.
4
Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.用恶性疟原虫重组抗原免疫后对夜猴的保护作用。
Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:413-22. doi: 10.1590/s0074-02761992000700070.
5
Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.分泌裂殖子表面蛋白1(MSP1)的重组牛分枝杆菌卡介苗,依赖于MSP1刺激的γ干扰素和寄生虫特异性抗体,诱导对啮齿动物疟原虫感染的保护作用。
J Exp Med. 1998 Sep 7;188(5):845-54. doi: 10.1084/jem.188.5.845.
6
Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.一种嵌合恶性疟原虫裂殖子表面蛋白疫苗在夜猴中的免疫原性。
Malar J. 2016 Mar 15;15:159. doi: 10.1186/s12936-016-1226-5.
7
Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1.基于间日疟原虫AMA-1和MSP1的新型嵌合重组蛋白的产生、表征及免疫原性
Vaccine. 2017 Apr 25;35(18):2463-2472. doi: 10.1016/j.vaccine.2017.03.023. Epub 2017 Mar 22.
8
Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.恶性疟原虫:在重组痘苗病毒感染的细胞中对传播阻断疫苗候选物Pfs48/45进行异源合成。
Exp Parasitol. 1998 Oct;90(2):165-74. doi: 10.1006/expr.1998.4315.
9
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.基于恶性疟原虫顶端膜抗原1(PfAMA1)的DNA、蛋白质和重组改良安卡拉痘苗疫苗的初免-加强免疫方案在小鼠中诱导的免疫反应。
Vaccine. 2006 Sep 11;24(37-39):6187-98. doi: 10.1016/j.vaccine.2006.05.099. Epub 2006 Jun 12.
10
Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.采用初免-加强免疫策略对间日疟原虫和恶性疟原虫 MSP-1 共同免疫诱导的免疫应答。
Parasite Immunol. 2011 Nov;33(11):594-608. doi: 10.1111/j.1365-3024.2011.01331.x.

引用本文的文献

1
Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate.基于天花病毒的严重急性呼吸综合征冠状病毒 2 疫苗候选物的免疫原性。
Front Immunol. 2022 Jul 22;13:911164. doi: 10.3389/fimmu.2022.911164. eCollection 2022.
2
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.一到两次注射基于痘苗病毒载体的疫苗可保护hACE2转基因小鼠免受新冠病毒上、下呼吸道感染。
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12). doi: 10.1073/pnas.2026785118.
3
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease.
MVA载体疫苗可抑制转基因小鼠上、下呼吸道中的SARS-CoV-2复制并预防致死性疾病。
bioRxiv. 2021 Jan 1:2020.12.30.424878. doi: 10.1101/2020.12.30.424878.
4
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.基于表达非洲马瘟病毒 VP2 抗原的改良安卡拉痘苗病毒(MVA)的重组疫苗的免疫原性取决于递送到宿主的表达 VP2 蛋白的水平。
Antiviral Res. 2018 Jun;154:132-139. doi: 10.1016/j.antiviral.2018.04.015. Epub 2018 Apr 18.
5
Enhancing poxvirus vectors vaccine immunogenicity.增强痘病毒载体疫苗的免疫原性。
Hum Vaccin Immunother. 2014;10(8):2235-44. doi: 10.4161/hv.28974.
6
Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.利用痘病毒载体疫苗诱导抗体:进展与展望。
Vaccine. 2013 Sep 6;31(39):4223-30. doi: 10.1016/j.vaccine.2013.05.091. Epub 2013 Jun 5.